SB 115, as introduced, Hill. Stem cell research: Independent Citizen’s Oversight Committee.
The California Stem Cell Research and Cures Act, an initiative measure approved by the voters at the November 2, 2004, statewide general election as Proposition 71, establishes the California Institute for Regenerative Medicine, the purpose of which is, among other things, to make grants and loans for stem cell research. Existing law establishes the Independent Citizen’s Oversight Committee (ICOC), which is required to perform various functions and duties with regard to the operation of the institute. Existing law authorizes the ICOC to annually modify its funding and finance programs to optimize the institute’s ability to achieve the objective that its activities be revenue-positive for the state during its first 5 years of operation without jeopardizing the progress of its core medical and scientific research program.
This bill would make a nonsubstantive change to that provision.
Vote: majority. Appropriation: no. Fiscal committee: no. State-mandated local program: no.
The people of the State of California do enact as follows:
Section 125290.40 of the Health and Safety Code
2 is amended to read:
ICOC Functions
P2 1The ICOC shall perform the following functions:
2(a) Oversee the operations of the institute.
3(b) Develop annual and long-term strategic research and
4financial plans for the institute.
5(c) Make final decisions on research standards and grant awards
6in California.
7(d) Ensure the completion of an annual financial audit of the
8institute’s operations.
9(e) Issue public reports on the activities of the institute.
10(f) Establish policies regarding intellectual property rights
11arising from research funded by the institute.
12(g) Establish rules and guidelines for the operation of the ICOC
13and its working groups.
14(h) Perform all other acts necessary or appropriate in the exercise
15of its power, authority, and jurisdiction over the institute.
16(i) Select members of the working groups.
17(j) Adopt, amend, and rescind rules and regulations to carry out
18the purposes and provisions of this chapter, and to govern the
19procedures of the ICOC. Except as provided in subdivision (k),
20these rules and regulations shall be adopted in accordance with
21the Administrative Procedure Act (Government Code, Title 2,
22Division 3, Part 1, Chapter 4.5, Sections 11371 et seq.).
23(k) Notwithstanding the Administrative Procedure Act (APA),
24and in order to facilitate the immediate commencement of research
25covered by this chapter, the ICOC may adopt interim regulations
26without compliance with the procedures set forth in the APA. The
27interim regulations shall remain in effect for 270 days unless earlier
28superseded by regulations adopted pursuant to the APA.
29(l) Request the issuance of bonds from the California Stem Cell
30Research and Cures Finance Committee and loans from the Pooled
31Money Investment Board.
32(m) May annually modify its funding and finance programs to
33optimize the institute’s ability to achieve the objective that its
34activities be revenue-positive for thebegin delete State of Californiaend deletebegin insert
stateend insert during
35its first five years of operation without jeopardizing the progress
36of its core medical and scientific research program.
37(n) Notwithstanding Section 11005 of the Government Code,
38accept additional revenue and real and personal property, including,
39but not limited to, gifts, royalties, interest, and appropriations that
P3 1may be used to supplement annual research grant funding and the
2operations of the institute.
3(o) Under the guidance of the ICOC, the institute shall create a
4succession plan addressing changes in leadership of both the
5institute and the ICOC designed to minimize disruption and adverse
6impacts to the activities of the institute. A copy of the succession
7plan shall be transmitted to the Governor, Controller, and the
8Legislature within 30 days of its completion. The succession plan
9should include, but is not limited
to:
10(1) An assessment of leadership needs before beginning a search.
11(2) An outline of succession procedures.
12(3) Strategies to ensure successful knowledge transfer.
O
99